 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pacer Advisors Inc. decreased its stake in Seagen Inc. (NASDAQ:SGEN  Free Report) by 46.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities  Exchange...

Seagen Inc. (NASDAQ:SGEN) Shares Sold by Pacer Advisors Inc.

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Seagen Inc (SGEN), where a total volume of 93,902 contracts has been traded thus...

Noteworthy Tuesday Option Activity: SGEN, ICPT, KALV

Seagen Inc. (Nasdaq: SGEN) and Astellas Pharma Inc. (TSE:4503) today announced positive topline results from the Phase 3 EV-302 clinical trial (also known as KEYNOTE-A39) for PADCEV (enfortumab...

PADCEV (enfortumab vedotin-ejfv) and KEYTRUDA (pembrolizumab) Significantly Improve Overall Survival and Progression-Free Survival in Patients With Previously Untreated Advanced Bladder Cancer in Pivotal Phase 3 EV-302 Trial

PADCEV (enfortumab vedotin-ejfv) and KEYTRUDA (pembrolizumab) Significantly Improve Overall Survival and Progression-Free Survival in Patients With Previously Untreated Advanced Bladder Cancer in...

Seagen Inc. (NASDAQ:SGEN  Get Free Report) has been assigned an average recommendation of Hold from the seventeen ratings firms that are currently covering the company...

Seagen Inc. (NASDAQ:SGEN) Given Average Rating of "Hold" by Analysts

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Seagen Inc (SGEN), where a total of 6,758 contracts have traded so far, representing...

Notable Monday Option Activity: SGEN, MSM, NXST

Seagen Inc. (NASDAQ:SGEN  Get Free Report) insider Vaughn B. Himes sold 8,785 shares of Seagen stock in a transaction that occurred on Thursday, September 7th. The stock was sold at an average...

Vaughn B. Himes Sells 8,785 Shares of Seagen Inc. (NASDAQ:SGEN) Stock

Insider Sell: Seagen Inc's CTO Vaughn Himes Sells 8,785 Shares

Aviva PLC lowered its position in Seagen Inc. (NASDAQ:SGEN  Free Report) by 85.6% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission...

Seagen Inc. (NASDAQ:SGEN) Shares Sold by Aviva PLC

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Seagen, Genmab announce Phase 3 innovaTV 301 trial met primary endpoint of OS

Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA.

Watchers	4,385
52-Wk Low	$116.08
52-Wk High	$217.08

Market Cap	$39.9B
Volume (M)	367,487.00
52-Wk High	$217.08
52-Wk Low	$116.08

SGEN Seagen Inc

About

Feed

News

Sentiment

Earnings

Fundamentals